Hyongbum Henry Kim

Hyongbum Henry Kim

Auto-generated profile, based on publicly available information

Hyongbum Henry Kim

Department of Pharmacology, Yonsei University College of Medicine, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2014 in Nature Reviews Genetics
Verified
Journal Article
Closed access
HKHyongbum Kim
Hyongbum Kim
JKJin-Soo Kim
Jin-Soo Kim

2 April 2014 in Genome Research
Verified
Journal Article
Open access
PDF file
SRSuresh Ramakrishna
Suresh Ramakrishna
ADAbu-Bonsrah Kwaku Dad
Abu-Bonsrah Kwaku Dad
JBJagadish Beloor
Jagadish Beloor
RGRamu Gopalappa
Ramu Gopalappa
SLSang-Kyung Lee
Sang-Kyung Lee
HKHyongbum Kim
Hyongbum Kim
RNA-guided endonucleases (RGENs) derived from the CRISPR/Cas system represent an efficient tool for genome editing. RGENs consist of two components: Cas9 protein and guide RNA. Plasmid-mediated delivery of these components into cells can result in uncontrolled integration of the plasmid sequence into the host genome, and unwanted immune responses and potential safety problems that can be caused by the bacterial sequences. Furthermore, this delivery method requires transfection tools. Here we show that simple treatment with cell-penetrating peptide (CPP)–conjugated recombinant Cas9 protein and CPP-complexed guide RNAs leads to endogenous gene disruptions in human cell lines. The Cas9 protein was conjugated to CPP via a thioether bond, whereas the guide RNA was complexed with CPP, forming condensed, positively charged nanoparticles. Simultaneous and sequential treatment of human cells, including embryonic stem cells, dermal fibroblasts, HEK293T cells, HeLa cells, and embryonic carcinoma cells, with the modified Cas9 and guide RNA, leads to efficient gene disruptions with reduced off-target mutations relative to plasmid transfections, resulting in the generation of clones containing RGEN-induced mutations. Our CPP-mediated RGEN delivery process provides a plasmid-free and additional transfection reagent–free method to use this tool with reduced off-target effects. We envision that our method will facilitate RGEN-directed genome editing.

29 January 2018 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
HKHui Kwon Kim
Hui Kwon Kim
SMSeonwoo Min
Seonwoo Min
MSMyungjae Song
Myungjae Song
SJSoobin Jung
Soobin Jung
JCJae Woo Choi
Jae Woo Choi
HKHyongbum (Henry) Kim
Hyongbum (Henry) Kim

19 December 2016 in Nature Methods
Verified
Journal Article
Closed access
HKHui K Kim
Hui K Kim
MSMyungjae Song
Myungjae Song
Jinu LeeJinu Lee
Jinu Lee
AMA Vipin Menon
A Vipin Menon
SJSoobin Jung
Soobin Jung
HKHyongbum Kim
Hyongbum Kim

21 September 2020 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
HKHui Kwon Kim
Hui Kwon Kim
GYGoosang Yu
Goosang Yu
JPJinman Park
Jinman Park
SMSeonwoo Min
Seonwoo Min
SLSungtae Lee
Sungtae Lee
HKHyongbum Henry Kim
Hyongbum Henry Kim

1 November 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
HKHui Kwon Kim
Hui Kwon Kim
YKYounggwang Kim
Younggwang Kim
SLSungtae Lee
Sungtae Lee
SMSeonwoo Min
Seonwoo Min
JBJung Yoon Bae
Jung Yoon Bae
HKHyongbum Henry Kim
Hyongbum Henry Kim
A deep learning–based model predicts activity of a widely used genome editing tool in a highly accurate manner.